Cash Flow from Investing Activities: The total change in cash resulting from a company's investments.
Viking Therapeutics, Inc. (VKTX) had Cash Flow from Investing Activities of $265.78M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-90.79M |
|
-- |
|
-- |
|
$98.56M |
|
$-98.56M |
|
$7.77M |
|
$-90.79M |
|
$-90.80M |
|
$-90.79M |
|
$-90.79M |
|
$-90.79M |
|
$-90.80M |
|
$-98.56M |
|
$-100.47M |
|
112.32M |
|
112.32M |
|
$-0.81 |
|
$-0.81 |
|
| Balance Sheet Financials | |
$738.70M |
|
-- |
|
$0.71M |
|
$739.41M |
|
$26.07M |
|
-- |
|
$0.32M |
|
$26.39M |
|
$713.03M |
|
$713.03M |
|
$713.03M |
|
112.45M |
|
| Cash Flow Statement Financials | |
$-193.40M |
|
|
Cash Flow from Investing Activities |
$265.78M |
$1.34M |
|
$26.68M |
|
$100.38M |
|
$73.70M |
|
$32.23M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
28.34 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-193.40M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-12.73% |
|
-12.73% |
|
-12.28% |
|
-12.73% |
|
$6.34 |
|
$-1.72 |
|
$-1.72 |
|